Manufacturing is our core activity and our manufacturing plants are our main asset.
Strategically located in three continents: Europe, Asia and America, our 4 full cGMP state-of-the-art multipurpose sites with around 800m3 total reaction volume capacity guarantee the perfect solution for chemical and pharmaceutical intermediates or API’s.
Read more